Lemsip Multirelief capsules *
Pharmacy Only: Non-prescription

Updated on 27 October 2021

File name

IE SPC cleean Aug21_1635339496.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through pharmacy only

Updated on 15 January 2020

File name

Lemsip Multi Relief Capsules_1579099305.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 28 February 2018

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 28 February 2018

Reasons for updating

  • Change to section 9 - Date of first authorisation/renewal of the authorisation

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Approval of Renewal date added to Section 9 (Renewal approval received Jan 2018)

Updated on 02 March 2017

File name

PIL_14939_142.pdf

Reasons for updating

  • New PIL for new product

Updated on 02 March 2017

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 5 - how to store or dispose

Updated on 01 December 2016

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.5:
Additional information for paracetamol & phenylephrine HCl interactions

Section 4.6:
Additional safety data on phenylephrine HCl

Section 4.7:
Addition of "No or negligible influence on ability to drive or use machinery"

Section 4.8:
Addition of blood dyscrasias symptoms
Addition of hypersensitivity reactions as an adverse reaction for Guaifenesin.

Section 4.9:
Addition o f overdose data for paracetamol and phenylephrine HCl


Updated on 03 December 2012

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 6.3, the shelf-life has changed from 2-3 years
In section 10, the date of revision of the text has changed to November 2012

Updated on 30 March 2011

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

None provided

Updated on 29 March 2011

Reasons for updating

  • New PIL for new product